Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation
The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.
Abstract
The present multicenter double-blind placebo-controlled trial evaluates the therapeutic effectiveness of small-volume daily doses of an isosmotic polyethylene glycol (PEG) electrolyte solution in the treatment of chronic nonorganic constipation. After a complete diagnostic investigation, patients still constipated at the end of a four-week placebo-treatment run-in period were enrolled and randomized to receive either placebo or PEG solution 250 ml twice a day for the following eight weeks. Patients were assessed at four and eight weeks of treatment, and they reported frequency and modality of evacuation, use of laxatives, and relevant symptoms daily on a diary card. Oroanal and segmental large-bowel transit times were assessed with radiopaque markers during the fourth week of the run-in period and the last week of the treatment period. During the study period, dietary fiber and liquids were standardized and laxatives were allowed only after five consecutive days without a bowel movement. Of the 55 patients enrolled, five dropped out, three because of adverse events and two for reasons unrelated to therapy; another two were excluded from the efficacy analysis because of protocol violation. Of the remaining 48 patients (37 women, age 42 +/- 15 years, mean +/- SD), 23 were assigned to placebo and 25 to PEG treatment. In comparison to placebo, PEG solution induced a statistically significant increase in weekly bowel frequency at four weeks and at the end of the study (PEG: 4.8 +/…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and SBMs per week (MD 2.30, CI 1.55-3.06), based on meta-analyzed data from 3 studies. 37-39”
In the citing paper
“Across 2 studies, a higher rate of individuals met the responder definition, one study defined responder as normalization of bowel moments 37,38 and other defined based on the US Food and Drug Administration (FDA) end points, 40 compared with placebo (RR 3.13, CI 2.00-4.89); PEG was associated with 312 more per 1,000 (from 146 more to 569 more).”
Citations
Cites
Davis, G. R., Santa Ana, C. A., Morawski, S. G., & Fordtran, J. S. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90781-7 · Cited by 550
CHADWICK, V. S., Phillips, S. F., & Hofmann, A. F. (1977) · PubMed · Cited by 190
Measurements of Intestinal Permeability Using Low Molecular Weight Polyethylene Glycols (PEG 400)
CHADWICK, V. S., Phillips, S. F., & Hofmann, A. F. (1977) · Gastroenterology · doi:10.1016/s0016-5085(19)32196-1 · Cited by 145
Management of chronic constipation.
Clayden, G. S. (1992) · Archives of Disease in Childhood · doi:10.1136/adc.67.3.340 · Cited by 128
Badiali, D., Corazziari, E., Habib, F. I., Tomei, E., Bausano, G., Magrini, P., Anzini, F., & Torsoli, A. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02065421 · Cited by 127
Self-citationErnstoff, J. J., Howard, D. A., Marshall, J. B., Jumshyd, A., & McCullough, A. J. (1983) · Gastroenterology · doi:10.1016/0016-5085(83)90373-6 · Cited by 121 · cited 1×
“The usual doses range from 2 to 4 liters, and its cleansing efficacy and its tolerability have been well established (12).”
BackgroundA low-sodium solution for gastrointestinal lavage
Fordtran, J. S., Ana, C. A. S., & Cleveland, M. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91284-d · Cited by 100
Brady, C. E., DiPalma, J. A., Morawski, S. G., Ana, C. A. S., & Fordtran, J. S. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90261-1 · Cited by 96
TOLIA, V., LIN, C. ‐., & SUR, Y. F. (1993) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1993.tb00128.x · Cited by 94 · cited 1×
“Experience with orthograde whole-gut irrigation in preparing for colon investigation and surgery (4) initially using an electrolyte solution and later an isosmotic polyethylene glycol electrolyte solution .(PEG) has led to its use in the acute treatment of both fecal impaction (5, 6 ) and severe constipation (7, 8). R…”
MethodAndorsky, R. I., & Goldner, F. (1990) · PubMed · Cited by 84
Research works printed but not linked: 4
- Whitehead WE, Chaussade S, Corazziari E, Kumar D: Report of an international workshop on management of constipation. Gastroenterol Int 4:99–113, 1991
- Baldonedo YC, Lugo E, Uzcategui AA, Guelrud M, Skornicki J: Evaluacion y uso del polietilen glicol en pacientes constipados. Gen (Venezuela) 45:294–297, 1991
- Corazziari E, Dani S, Possessere C, Anzini F, Torsoli A. Colonic segmental transit times in non-organic constipation. Rend Gastroenterol 7:67–69, 1975
- Saggioro A: Trattamento della stipsi in ambito geriatrico con una soluzione di lavaggio gastrointestinale. Risultati di uno studio controllato. Il Gastroenterologo 6:19–21, 1992
Cited by
Gastrointestinal dysfunction in Parkinson's disease
Pfeiffer, R. F. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00307-7 · Cited by 925
Lembo, A., & Camilleri, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020995 · Cited by 692
Ford, A. C., Moayyedi, P., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Quigley, E. M. M. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.187 · Cited by 645
Efficacy and Safety of Traditional Medical Therapies for Chronic Constipation: Systematic Review
Ramkumar, D., & Rao, S. S. C. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40925.x · Cited by 494
“Constipation was variously defined, with only two studies utilizing the Rome criteria to identify suitable patients (13, 14).”
MethodConstipation in Infants and Children: Evaluation and Treatment
Baker, S. S., Liptak, G. S., Colletti, R. B., Croffie, J. M., Di Lorenzo, C., Ector, W., & Nurko, S. (1999) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1999.tb02634.x · Cited by 431
Rao, S. S. C., Camilleri, M., Hasler, W. L., Maurer, A. H., Parkman, H. P., Saad, R., Scott, M. S., Simren, M., Soffer, E., & Szarka, L. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01612.x · Cited by 379
Ford, A. C., & Suares, N. C. (2011) · Gut · doi:10.1136/gut.2010.227132 · Cited by 378
“27 30 31 No significant differences were detected in rates of abdominal pain, reported in all four trials containing 853 patients, or headache, reported in three RCTs containing 486 patients.(26) 27 31 Diarrhoea occurred significantly more frequently in two trials containing 735 patients (RR1⁄413.”
BackgroundSystematic Review on the Management of Chronic Constipation in North America
Brandt, L. J., Prather, C. M., Quigley, E. M. M., Schiller, L. R., Schoenfeld, P., & Talley, N. J. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.50613_2.x · Cited by 342
Attar, A., Lémann, M., Ferguson, A., Halphen, M., Boutron, M.-C., Flourié, B., Alix, E., Salmeron, M., Guillemot, F., Chaussade, S., et al. (1999) · Gut · doi:10.1136/gut.44.2.226 · Cited by 279
Childhood Constipation: Is There New Light in The Tunnel?
Benninga, M. A., Voskuijl, W. P., & Taminiau, J. A. J. M. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2004.tb00890.x · Cited by 266
Serra, J., Pohl, D., Azpiroz, F., Chiarioni, G., Ducrotté, P., Gourcerol, G., Hungin, A. P. S., Layer, P., Mendive, J., Pfeifer, J., et al. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13762 · Cited by 244
Voskuijl, W., de Lorijn, F., Verwijs, W., Hogeman, P., Heijmans, J., Mäkel, W., Taminiau, J., & Benninga, M. (2004) · Gut · doi:10.1136/gut.2004.043620 · Cited by 215
Osmotic and stimulant laxatives for the management of childhood constipation
Gordon, M., MacDonald, J. K., Parker, C. E., Akobeng, A. K., & Thomas, A. G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009118.pub3 · Cited by 182
Corazziari, E., Badiali, D., Bazzocchi, G., Bassotti, G., Roselli, P., Mastropaolo, G., Lucà, M. G., Galeazzi, R., & Peruzzi, E. (2000) · Gut · doi:10.1136/gut.46.4.522 · Cited by 202
Self-citationBove, A. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i14.1555 · Cited by 188
Chang, L., Chey, W. D., Imdad, A., Almario, C. V., Bharucha, A. E., Diem, S., Greer, K. B., Hanson, B., Harris, L. A., Ko, C., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.03.214 · Cited by 185
Gallagher, P., & O’Mahony, D. (2009) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2009.09.001 · Cited by 163
Nelson, A. D., Camilleri, M., Chirapongsathorn, S., Vijayvargiya, P., Valentin, N., Shin, A., Erwin, P. J., Wang, Z., & Murad, M. H. (2017) · Gut · doi:10.1136/gutjnl-2016-311835 · Cited by 158
Bove, A. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i36.4994 · Cited by 151
Constipation: Evaluation and Treatment of Colonic and Anorectal Motility Disorders
Rao, S. S. C. (2007) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2007.07.013 · Cited by 155
A review of laxative therapies for treatment of chronic constipation in older adults
Fleming, V. H., & Wade, W. E. (2010) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/s1543-5946(10)80003-0 · Cited by 151
Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis
Luthra, P., Camilleri, M., Burr, N. E., Quigley, E. M. M., Black, C. J., & Ford, A. C. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30246-8 · Cited by 138
Rao, S. S. C. (2003) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(03)00026-8 · Cited by 125
Lack of Objective Evidence of Efficacy of Laxatives in Chronic Constipation
Jones, M. P., Talley, N. J., Nuyts, G., & Dubois, D. J. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1020131126397 · Cited by 122
“Of the 28 studies excluded (20–47), the reasons were incompatible outcome assessments (N 13) (20, 21, 25, 28, 31, 33, 38–40, 43, 44, 46, 47), no variance data (N 8) (22–24, 34–36, 41, 42), not a randomized trial (N 2), (30, 45), lack of numeric data (N 1) (32), inadequate sample size (N 2) (27, 37), and not a laxative…”
Freedman, M. D., Schwartz, H. J., Roby, R., & Fleisher, S. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04264.x · Cited by 106
Shin, J. E., Jung, H., Lee, T. H., Jo, Y., Lee, H., Song, K. H., Hong, S. N., Lim, H. C., Lee, S. J., Chung, S. S., et al. (2016) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15185 · Cited by 111
Seinelä, L., Sairanen, U., Laine, T., Kurl, S., Pettersson, T., & Happonen, P. (2009) · Drugs & Aging · doi:10.2165/11316470-000000000-00000 · Cited by 95
Bharucha, A. E. (2007) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2007.07.001 · Cited by 125
Chronic Constipation: Current Treatment Options
Liu, L. W. C. (2011) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2011/360463 · Cited by 88
Sgouros, S. N. (2005) · Gut · doi:10.1136/gut.2005.082099 · Cited by 89
“Polyethylene glycol electrolyte balanced solutions (PEG) are osmotic laxatives frequently used for the management of chronic functional constipation (12-14).”
BackgroundSharma, A., Rao, S. S. C., Kearns, K., Orleck, K. D., & Waldman, S. A. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16369 · Cited by 84
Constipation, diarrhea, and symptomatic hemorrhoids during pregnancy
Wald, A. M. (2003) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(02)00069-9 · Cited by 83
“Polyethylene glycol (PEG) has been approved recently as an osmotic agent for chronic constipation in daily doses of 8 to 25 g [15].”
BackgroundParé, P., Bridges, R., Champion, M. C., Ganguli, S. C., Gray, J. R., Irvine, E. J., Plourde, V., Poitras, P., Turnbull, G. K., Moayyedi, P., et al. (2007) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2007/848706 · Cited by 81
“There is a need for RCTs on MgOH in CC and IBS-C.”
BackgroundInfluentialOpioid-Induced Bowel Dysfunction
Ketwaroo, G. A., Cheng, V., & Lembo, A. J. (2013) · Current Gastroenterology Reports · doi:10.1007/s11894-013-0344-2 · Cited by 87
Clinical trial guidelines for pharmacological treatment of irritable bowel syndrome
Corazziari, E., Bytzer, P., Delvaux, M., Holtmann, G., Malagelada, J. R., Morris, J., Muller‐Lissner, S., Spiller, R. C., Tack, J., & Whorwell, P. J. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01709.x · Cited by 80
Self-citationConstipation: Evaluation and Treatment of Colonic and Anorectal Motility Disorders
Rao, S. S. C. (2009) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2008.12.006 · Cited by 88
Pharmacological management of constipation
Emmanuel, A. V., Tack, J., Quigley, E. M., & Talley, N. J. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01403.x · Cited by 76
Paré, P., & Fedorak, R. N. (2014) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2014/631740 · Cited by 71
“Stool consistency was better at 0.4 and 0.8 g/kg/day; P<0.001 Andorsky and Goldner (29), 1990 Controlled, doubleblinded, randomized, cross-over (5 days + 5 days) PEG+E (8 or 16 oz/ day) (n=32, n/a) Placebo (8 or 16 oz/day) Mean BM/week PEG+E 7.75±4.55 vs placebo 4.88±2.62; P<0.01 Mean stool consistency PEG+E 2.56±1.17…”
BackgroundInfluentialSystematic review and meta analysis: polyethylene glycol in adults with non-organic constipation
Belsey, J. D., Geraint, M., & Dixon, T. A. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02397.x · Cited by 70
Update on constipation: One treatment does not fit all
Foxx–Orenstein, A. E., McNALLY, M. A., & Odunsi, S. T. (2008) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.75.11.813 · Cited by 69
Systematic Review on the Management of Chronic Constipation in North America
Brandt, L. J., Prather, C. M., Quigley, E. M. M., Schiller, L. R., Schoenfeld, P., & Talley, N. J. (2005) · American Journal of Gastroenterology · doi:10.14309/00000434-200507001-00002 · Cited by 63
Gordon, M., Naidoo, K., Akobeng, A. K., & Thomas, A. G. (2013) · Evidence-Based Child Health A Cochrane Review Journal · doi:10.1002/ebch.1893 · Cited by 61
Bharucha, A. E., & Phillips, S. F. (2001) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70168-0 · Cited by 70
Management of Chronic Constipation in the Elderly
Gallagher, P., O’Mahony, D., & Quigley, E. M. M. (2008) · Drugs & Aging · doi:10.2165/00002512-200825100-00001 · Cited by 65
Agents that act luminally to treat diarrhoea and constipation
Menees, S. B., Saad, R. J., & Chey, W. D. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.162 · Cited by 61
GIORGIO, R. D., Zucco, F., Chiarioni, G., Mercadante, S., Corazziari, E. S., Caraceni, A. T., Odetti, P. R., Giusti, R., Marinangeli, F., & Pinto, C. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01766-y · Cited by 67
Self-citationConsenso Latinoamericano de Estreñimiento Crónico
Wasserman, M. S., Francisconi, C. F. D. M., Olden, K. W., Aguilar-Paiz, L., Bustos-Fernández, L. M., Cohen, H., Passos, M. D. C. F., González-Martínez, M. A., Iade, B., Iantorno, G., et al. (2008) · Gastroenterología y Hepatología · doi:10.1157/13116072 · Cited by 74
Chronic Constipation: Current Treatment Options
Liu, L. W. (2011) · Canadian Journal of Gastroenterology · doi:10.1155/2011/930108 · Cited by 74
Every‐Palmer, S., Ellis, P., Nowitz, M., Stanley, J., Grant, E., Huthwaite, M., & Dunn, H. (2016) · CNS Drugs · doi:10.1007/s40263-016-0391-y · Cited by 52
Functional Constipation: Individualising Assessment and Treatment
Pannemans, J., Masuy, I., & Tack, J. (2020) · Drugs · doi:10.1007/s40265-020-01305-z · Cited by 55
Effectiveness of laxatives in adults
Petticrew, M. (2001) · Quality in Health Care · doi:10.1136/qhc.0100268 · Cited by 56
Chang, L., Chey, W. D., Imdad, A., Almario, C. V., Bharucha, A. E., Diem, S. J., Greer, K. B., Hanson, B., Harris, L. A., Ko, C. W., et al. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002227 · Cited by 56
“Twoof these studies were multicenter trials conducted in Italy and enrolled participants aged 18–70 years with chronic constipation defined in accordance with the Rome criteria, that is, less than 2 bowelmovements per week for at least 12 months or the presence of 2 or more of the following symptoms: ,3 bowel movement…”
BackgroundMethodResultInfluentialChronic constipation and abdominal pain: Independent or closely interrelated symptoms?
Wong, M. Y. W., Hebbard, G., Gibson, P. R., & Burgell, R. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14970 · Cited by 49
2022 Seoul Consensus on Clinical Practice Guidelines for Functional Constipation
Cho, Y. S., Lee, Y. J., Shin, J. E., Jung, H., Park, S., Kang, S. J., Song, K. H., Kim, J., Lim, H. C., Park, H. S., et al. (2023) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm23066 · Cited by 53
Lubiprostone: Chloride channel activator for chronic constipation
Rivkin, A. M., & Chagan, L. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.12.013 · Cited by 37
Wald, A. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70284-4 · Cited by 36
Shin, J. E., Jung, H., Lee, T. H., Jo, Y., Lee, H., Song, K. H., Hong, S. N., Lim, H. C., Lee, S. J., Chung, S. S., et al. (2016) · Korean Journal of Medicine · doi:10.3904/kjm.2016.91.2.114 · Cited by 34
Use of polyethylene glycol in functional constipation and fecal impaction
Mínguez, M., Higueras, A. L., & Júdez, J. (2016) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2016.4571/2016 · Cited by 44
“Features of the selected studies Comparison Number of studies Total of Patients Patients with PEG Patients Comparator References PEG or PEG + E/placebo* 12 1,099 799 551 (2-11,28,29) PEG o PEG + E/lactulose 8 761 402 396 (26,27,30-35) PEG/PEG + E 5 532 269 263 (12,13,36,37,58) PEG/milk of magnesia 2 168 85 83 (38,39)…”
BackgroundMethodAdvances in the management of pediatric constipation
Nurko, S. (2000) · Current Gastroenterology Reports · doi:10.1007/s11894-000-0066-0 · Cited by 34
Pathophysiology, diagnosis and current management of chronic constipation
Wald, A. M. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0406 · Cited by 36
Osmotic and stimulant laxatives for the management of childhood constipation
Gordon, M. A., Naidoo, K., Akobeng, A. K., & Thomas, A. G. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009118.pub2 · Cited by 43
Migeon-Duballet, I., Chabin, M., Gautier, A., Mistouflet, T., Bonnet, M., Aubert, J. M., & Halphen, M. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x112543 · Cited by 32
The Mexican consensus on chronic constipation
Remes-Troche, J. M., Coss‐Adame, E., López‐Colombo, A., Amieva‐Balmori, M., Sánchez, R. C., Guindic, L. C., Rendón, R. F., Escudero, O. G., Martínez, M. G., Chávez, M. E. I., et al. (2018) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2018.05.012 · Cited by 37
Katelaris, P., Naganathan, V., Liu, K., Krassas, G., & Gullotta, J. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0457-9 · Cited by 43
“Corazziari E 1996 [20] PEG4000 + E Placebo NA No difference in tolerability of PEG + E vs placebo.”
BackgroundPfeiffer, R. F., & Quigley, E. M. M. (1999) · CNS Drugs · doi:10.2165/00023210-199911060-00003 · Cited by 33
SLOOTS, C. E. J., & FELT‐BERSMA, R. J. F. (2002) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.2002.00304.x · Cited by 31
Efficacy and safety of prucalopride in adults and children with chronic constipation
Diederen, K., Mugie, S. M., & Benninga, M. A. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.996547 · Cited by 29
“High-quality trials have only shown efficacy of osmotic laxatives and stimulant laxatives for stool frequency and consistency [16-20].”
BackgroundWang, Y., Wang, B., Jiang, X., Jiang, M., Xu, C., SHAO, C., Jia, L.-Y., Huang, Z., Xu, X., Liu, H., et al. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.491 · Cited by 27
“A number of clinical studies have demonstrated that PEG 4000 is effective in the treatment of constipation in adults and children (3-7).”
BackgroundCurrent management strategies and therapeutic targets in chronic constipation
Emmanuel, A. V. (2010) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x10384173 · Cited by 27
“…have been subject to a larger number of clinical trials than other agents: there are five placebo-controlled studies [Cleveland et al. 2001; Corazziari et al. 2000, 1996; Di Palma et al. 2000; Andorsky and Gordner, 1990] and two lactulose-controlled ones [Attar et al. 1999; Freedman et al.…”
BackgroundMethodTse, Y., Armstrong, D., Andrews, C. N., Bitton, A., Bressler, B. L., Marshall, J. K., & Liu, L. W. C. (2017) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2017/8612189 · Cited by 28
Mueller‐Lissner, S., & Wald, A. M. (2010) · Europe PMC (PubMed Central) · Cited by 25
Paré, P., Bridges, R. J., Champion, M. C., Ganguli, S. C., Gray, J. R., Irvine, E. J., Plourde, V., Poitras, P., Turnbull, G. K., Moayyedi, P., et al. (2007) · Canadian Journal of Gastroenterology · doi:10.1155/2007/625783 · Cited by 38
Constipation in Parkinson's Disease
Quigley, E. M. M. (2023) · Seminars in Neurology · doi:10.1055/s-0043-1771457 · Cited by 28
Bharucha, A. E., & Philips, S. F. (2001) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-001-0056-9 · Cited by 23
Esmaeili-dooki, M. R., Mozaffarpur, S. A., Mirzapour, M., Shirafkan, H., Kamalinejad, M., & Bijani, A. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.33998 · Cited by 23
“In some of those trials, PEG was compared with lactulose (10, 21-27), in two of them with milk of magnesia (28, 29), two with liquid paraffin (30, 31), in one study with a natural product (mixture of Acacia fiber, Psyllium fiber and fructose) (32) and three with placebo (33-35).”
BackgroundMethodPractical Treatments for Constipation in Korea
Park, K.-S., Choi, S. C., Park, M. I., Shin, J.-E., Jung, K. W., Kim, S., Lee, T.-H., Koo, H. S., & Constipation Study Group in the Korean Society of Neurogastroenterology and Motility (2012) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2012.27.3.262 · Cited by 25
“These drugs are not absorbed in the intestine and maintain high osmosis in the colon [26-28].”
BackgroundEffects of therapeutic doses of lactulose vs. polyethylene glycol on isotopic colonic transit
JOUËT, P., Sabaté, J. M., Flourié, B., Cuillerier, E., Dj, G., Lémann, M., Jian, R., & Coffin, B. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03654.x · Cited by 23
Effects of polyethylene glycol 4000 on 24-h manometric recordings of left colonic motor activity
Hervé, S., Leroi, A., Mathiex‐Fortunet, H., Garnier, P., Karoui, S., Ménard, J.-F., Ducrotte, P. R., & Denis, P. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200106000-00006 · Cited by 22
Management of Chronic Constipation: A Comprehensive Review
Hojo, M., Shibuya, T., & Nagahara, A. (2023) · Internal Medicine · doi:10.2169/internalmedicine.2867-23 · Cited by 28
Systematic Review: FDA-Approved Prescription Medications for Adults With Constipation.
Cash, B. D., & Lacy, B. E. (2006) · Europe PMC (PubMed Central) · Cited by 27
Corsetti, M., Thys, A., Harris, A., Pagliaro, G., Deloose, E., Demedts, I., & Tack, J. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14040 · Cited by 20
The safety of available treatments for chronic constipation
Falcón, B. S., & Rey, E. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1361402 · Cited by 21
“In these, no differences in abdominal pain were detected in treatment with isotonic polyethylene glycol (PEG) [19,20] or stimulant laxatives, such as bisacodyl or sodium picosulfate [21,22], despite the fact that this has been a side effect traditionally associated with such treatments [14].”
BackgroundLitou, C., Effinger, A., Kostewicz, E. S., Box, K. J., Fotaki, N., & Dressman, J. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12983 · Cited by 28
“6 g) for 8 weeks did not significantly alter the transit time through the proximal colon, while the transit through the left colon and rectum was significantly accelerated (46 29 h vs 62 20 h and 37 42 vs 78 21 h, respectively).([48]) The results in eight patients with slow transit constipation were similar after admi…”
BackgroundGuidelines for the Treatment of Constipation
Park, M. I., Shin, J. E., Myung, S., Huh, K. C., Choi, C. H., Jung, S.-A., Choi, S. C., Sohn, C.-I., Choi, M., & The Korean Society of Neurogastroenterology and Motility (2011) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2011.57.2.100 · Cited by 20
“500명 이상의 만성 변비환자를 대상으로 한 9개의 잘 계획 된 연구에서 몇 가지 중요한 결과가 도출되었다.(53-61) 첫째, 매 일 PEG를 투여하면 배변 횟수를 정상화시키고(number needed to treat, NNT=2.”
Advancing treatment options for chronic idiopathic constipation
Quigley, E. M. M., & Neshatian, L. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1127356 · Cited by 19
Consenso mexicano sobre estreñimiento crónico
Remes-Troche, J. M., Coss‐Adame, E., López‐Colombo, A., Amieva‐Balmori, M., Sánchez, R. C., Guindic, L. C., Rendón, R. F., Escudero, O. G., Martínez, M. G., Chávez, M. E. I., et al. (2018) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2017.12.005 · Cited by 25
Coremans, G., Vos, R. D., Margaritis, V., Ghoos, Y. F., & Janssens, J. (2004) · Digestive and Liver Disease · doi:10.1016/j.dld.2004.09.016 · Cited by 17
Efficacy of Polyethylene Glycol in Constipated CAPD Patients
Mimidis, K., Mourvati, E., Kaliontzidou, M., Papadopoulos, V. P., Thodis, E. D., Kartalis, G., & Vargemezis, V. A. (2005) · Peritoneal Dialysis International · doi:10.1177/089686080502500618 · Cited by 16
“Clinical efficacy and tolerance were assessed using a daily diary card where the patient indicated (1) the number and consistency (1 to 5 scale, with 1 being hardest and 5 being loosest) of stools, (2) painful defecation, (3) rectal irritation, (4) flatus, and (5) blood in stools.”
MethodNew pharmacological treatment options for chronic constipation
Corsetti, M., & Tack, J. F. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.900543 · Cited by 15
“In addition, studies evaluating the effect of PEG on colonic transit showed accelerated transit mainly in the left colon [79], while prucalopride mainly enhances transit in the right colon [21,23].”
BackgroundTreatment for constipation: New and old pharmacological strategies
Lacy, B. E., Hussain, Z. H., & Mearin, F. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12335 · Cited by 17
Treatment of Chronic Constipation: Prescription Medications and Surgical Therapies.
Hussain, Z. H., Everhart, K. K., & Lacy, B. E. (2015) · PubMed · Cited by 15
Opioid-induced bowel dysfunction
Chang, H. Y., & Lembo, A. J. (2008) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-008-0002-1 · Cited by 14
Polyethylene glycol and prevalence of colorectal adenomas
Dorval, E. D., Jankowski, J. M., Barbieux, J.-P., Viguier, J., Bertrand, P., Brondin, B., Bougnoux, P., & Corpet, D. E. (2006) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(06)73511-4 · Cited by 14
“It is given orally for the treatment of chronic constipation [6-14], and was permitted for use for this indication in France in 1996, and in the USA and Canada in 2002.”
Lee, B. E., Lee, T. H., Kim, S., Park, K. S., Park, S., Shin, J. E., Jung, K. W., Choi, S. C., Hong, K. S., & Hong, S. N. (2015) · Korean Journal of Medicine · doi:10.3904/kjm.2015.88.1.1 · Cited by 11
Culbert, P., Gillett, H. R., & Ferguson, A. (1998) · Clinical Drug Investigation · doi:10.2165/00044011-199816050-00002 · Cited by 11
Emerging treatments for chronic constipation
Gudsoorkar, V. S., & Quigley, E. M. M. (2013) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2013.831068 · Cited by 10
“More recent arrivals such as lactulose [16,17] and PEG have shown to be effective in improving stool frequency and consistency in patients with CC in placebo-controlled studies [18-21].”
BackgroundFrizelle, F., & Barclay, M. L. (2004) · PubMed · Cited by 8
Bowel transit studies in children: evidence base, role and practicalities
Popescu, M., & Mutalib, M. (2021) · Frontline Gastroenterology · doi:10.1136/flgastro-2020-101719 · Cited by 7
Imanieh, M. H., Golpayegan, M. R., Sedighi, M., Ahmadi, K., Aghaie, A., Dehghani, S. M., & Yousefi, G. (2019) · Gastroenterology Review · doi:10.5114/pg.2019.84872 · Cited by 7
“Clinical studies have demonstrated that PEG is effective in the treatment of constipation in adults and children [17].”
BackgroundNEUROLOGIC DISORDERS AFFECTING THE ANORECTUM
Corazziari, E. S., Badiali, D., & Inghilleri, M. (2001) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70177-1 · Cited by 7
Self-citation
Metadata
- Authors
- Corazziari, E., Badiali, D., Habib, F. I., Reboa, G., Pitto, G., Mazzacca, G., Sabbatini, F., Galeazzi, R., Cilluffo, T., Vantini, I., Bardelli, E., & Baldi, F.
- Affiliations
- Sapienza University of Rome (IT)
- University of Genoa (IT)
- Venue
- Digestive Diseases and Sciences
- Published
- 1996-08
- Volume
- 41
- Issue
- 8
- Pages
- 1636-1642
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2028610080
- Cited by
- 135
- References
- 20
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 6 · 2021: 4 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 2 · 2016: 8 · 2015: 3 · 2014: 5 · 2013: 4 · 2012: 11
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
- Health Sciences › Medicine › Surgery › Enhanced Recovery After Surgery
- Keywords
- polyethylene glycol electrolyte solution, osmotic laxatives, stool frequency, stool consistency, laxative use, radiopaque markers
- MeSH terms
- Adolescent, Adult, Aged, Chronic Disease, Constipation, Defecation, Double-Blind Method, Electrolytes, Female, Gastrointestinal Transit, Humans, Male, Middle Aged, Polyethylene Glycols, Simethicone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.